SCHEMBL5574196

SCHEMBL5574196

CCCN1CCC(c2ccc(NS(=O)(=O)c3ccc(C(F)(F)F)cc3)cc2)C1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 3/20 0.48
DRD1 P21728 2/20 0.48
DRD4 P21917 2/20 0.48
DRD5 P21918 2/20 0.48
DRD3 P35462 2/20 0.48
LMNA P02545 2/20 0.45
ALDH1A1 P00352 1/20 0.45
TP53 P04637 1/20 0.45
MAPT P10636 1/20 0.45
ATM Q13315 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HTR6 P50406 2/20 0.44
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC8 Q9BY41 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5574190 1.00 DRD2 (0.48) DRD2DRD1DRD4DRD5DRD3
Hydrochloric Acid SCHEMBL1546145 0.99 DRD2 (0.47) DRD2DRD1DRD4DRD5DRD3
Hydrochloric Acid SCHEMBL1546142 0.99 DRD2 (0.47) DRD2DRD1DRD4DRD5DRD3
Hydrochloric Acid SCHEMBL4195930 0.91 DRD2 (0.47) DRD2DRD1DRD4DRD5DRD3
Hydrochloric Acid SCHEMBL4195935 0.91 DRD2 (0.47) DRD2DRD1DRD4DRD5DRD3
SCHEMBL1546874 0.89 ALDH1A1 (0.53) DRD2DRD1DRD4DRD5DRD3
SCHEMBL1546871 0.89 ALDH1A1 (0.53) DRD2DRD1DRD4DRD5DRD3
Hydrochloric Acid SCHEMBL4200941 0.88 DRD2 (0.45) DRD2DRD1DRD4DRD5DRD3
SCHEMBL1546115 0.88 DRD2 (0.55) DRD2DRD1DRD4DRD5DRD3
Hydrochloric Acid SCHEMBL4200948 0.88 DRD2 (0.45) DRD2DRD1DRD4DRD5DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1814849-A1 HETEROCYCLIC COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR Abbott GmbH & Co. KG (DE) 2007-08-08 EP disclosed
WO-2006040182-A1 HETEROCYCLIC COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR ABBOTT GMBH & CO. KG (DE) 2006-04-20 WO disclosed